Reshma Kewalramani
CIK 1735944 · CEO & President · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$56.77M
Companies
2
Total Filings
65
Lifetime Open-Market Net
-$74.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | CEO & President | 127,596 | $444.93 | $56.77M | -$74.81M | 59 | 2026-03-03 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 186,002 | $0.01 | $1.2K | $0 | 6 | 2024-06-14 |
Recent Filings · Page 7 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-24 | VRTX | Sell (S) | −638 | -$120.6K | EDGAR |
| 2019-05-17 | VRTX | Sell (S) | −241 | -$39.9K | EDGAR |
| 2019-02-21 | VRTX | Sell (S) | −1,488 | -$278.2K | EDGAR |
| 2019-02-08 | VRTX | Grant (A) | +13,315 | $0 | EDGAR |
| 2018-10-09 | VRTX | Sell (S) | −2,305 | -$430.9K | EDGAR |
Showing 61–65 of 65
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.